-
Je něco špatně v tomto záznamu ?
Reversal of hypermethylation and reactivation of the RARß gene by natural compounds in cervical cancer cell lines
A. K. Jha, M. Nikbakht, G. Parashar, A. Shrivastava, N. Capalash,J. Kaur
Jazyk angličtina Země Česko
NLK
Free Medical Journals
od 2000
Freely Accessible Science Journals
od 2000
ProQuest Central
od 2005-01-01
Health & Medicine (ProQuest)
od 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2000
- MeSH
- alylové sloučeniny farmakologie MeSH
- antitumorózní látky farmakologie terapeutické užití MeSH
- biologické přípravky farmakologie MeSH
- financování organizované MeSH
- genistein farmakokinetika terapeutické užití MeSH
- kurkumin farmakologie terapeutické užití MeSH
- lidé MeSH
- metylace DNA účinky léků MeSH
- nádorové buněčné linie MeSH
- nádory děložního čípku farmakoterapie genetika patofyziologie MeSH
- receptory kyseliny retinové genetika MeSH
- sulfidy farmakologie MeSH
- Check Tag
- lidé MeSH
- ženské pohlaví MeSH
Reactivation of tumour suppressor genes that have been silenced by promoter methylation is a very attractive molecular target for cancer therapy. The treatment of a squamous cervical cancer cell line, SiHa, with 20 µM curcumin and genistein resulted in demethylation of promoter of the RARß2 gene and led to the reactivation of the gene. The degree of methylation as observed by MSP decreased as the time period of treatment was increased from 72 h to 6 days. In HeLa cells (an adenocarcinoma cervical cancer cell line) there was also reversal of hypermethylation of the RARß2 gene after six days of treatment with 20 µM curcumin. However, allyl sulphide treatment (20 µM) did not cause the reversal of hypermethylation until 72 h of treatment in the SiHa cell line. This is the first report to show the reversal of hypermethylation of the RARß2 gene by genistein and curcumin in cervical cancer cell lines. Furthermore, these compounds acted as doublepronged agents as they caused apoptosis in the treated cervical cancer cell lines in addition to reversal of promoter hypermethylation.
Lit.: 15
- 000
- 00000naa 2200000 a 4500
- 001
- bmc11000681
- 003
- CZ-PrNML
- 005
- 20111210201530.0
- 008
- 110720s2010 xr e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Jha, A. K.
- 245 10
- $a Reversal of hypermethylation and reactivation of the RARß gene by natural compounds in cervical cancer cell lines / $c A. K. Jha, M. Nikbakht, G. Parashar, A. Shrivastava, N. Capalash,J. Kaur
- 314 __
- $a Dpt. of Biotechnology, Panjab University, Chandigarh
- 504 __
- $a Lit.: 15
- 520 9_
- $a Reactivation of tumour suppressor genes that have been silenced by promoter methylation is a very attractive molecular target for cancer therapy. The treatment of a squamous cervical cancer cell line, SiHa, with 20 µM curcumin and genistein resulted in demethylation of promoter of the RARß2 gene and led to the reactivation of the gene. The degree of methylation as observed by MSP decreased as the time period of treatment was increased from 72 h to 6 days. In HeLa cells (an adenocarcinoma cervical cancer cell line) there was also reversal of hypermethylation of the RARß2 gene after six days of treatment with 20 µM curcumin. However, allyl sulphide treatment (20 µM) did not cause the reversal of hypermethylation until 72 h of treatment in the SiHa cell line. This is the first report to show the reversal of hypermethylation of the RARß2 gene by genistein and curcumin in cervical cancer cell lines. Furthermore, these compounds acted as doublepronged agents as they caused apoptosis in the treated cervical cancer cell lines in addition to reversal of promoter hypermethylation.
- 650 _2
- $a financování organizované $7 D005381
- 650 _2
- $a alylové sloučeniny $x farmakologie $7 D000498
- 650 _2
- $a antitumorózní látky $x farmakologie $x terapeutické užití $7 D000970
- 650 _2
- $a biologické přípravky $x farmakologie $7 D001688
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a kurkumin $x farmakologie $x terapeutické užití $7 D003474
- 650 _2
- $a metylace DNA $x účinky léků $7 D019175
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a genistein $x farmakokinetika $x terapeutické užití $7 D019833
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a receptory kyseliny retinové $x genetika $7 D018168
- 650 _2
- $a sulfidy $x farmakologie $7 D013440
- 650 _2
- $a nádory děložního čípku $x farmakoterapie $x genetika $x patofyziologie $7 D002583
- 700 1_
- $a Nikbakht, M.
- 700 1_
- $a Parashar, G.
- 700 1_
- $a Shrivastava, A.
- 700 1_
- $a Capalash, N.
- 700 1_
- $a Kaur, J.
- 773 0_
- $w MED00011004 $t Folia biologica $g Roč. 56, č. 5 (2010), s. 195-200 $x 0015-5500
- 856 41
- $u https://fb.cuni.cz/Data/files/folia_biologica/volume_56_2010_5/fb2010A0026.pdf $y plný text volně přístupný
- 910 __
- $a ABA008 $b A 970 $c 89 $y 2
- 990 __
- $a 20110202122613 $b ABA008
- 991 __
- $a 20110727102110 $b ABA008
- 999 __
- $a ok $b bmc $g 827751 $s 692558
- BAS __
- $a 3
- BMC __
- $a 2010 $b 56 $c 5 $m Folia biologica (Praha) $x MED00011004 $d 195-200
- LZP __
- $a 2011-06/dkme